Colorectal Cancer Clinical Trials in Boston

Showing 181-200 of 268 trials

The National CT Colonography Trial

NCT00084929

RATIONALE: New diagnostic procedures such as computed tomographic colonography may improve the ability to detect colorectal cancer and may provide a less invasive method of detection. PURPOSE: This clinical trial is studying how well computed tomographic colonography works in screening healthy participants for colorectal cancer.

Colorectal Cancer

American College of Radiology Imaging Network2,600 participantsStarted Feb 2005

Scottsdale, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +11 more locations

TERMINATEDPhase 1< 1 mile

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

NCT02703571

Phase Ib dose escalation in advanced solid tumors to identify dose for Phase II dose expansion in advanced or metastatic pancreatic cancer and KRAS-mutant colorectal cancer. Open-label, nonrandomized.

Solid Tumors for Phase IbPancreatic Cancer for Phase IIColorectal Cancer for Phase II

Novartis Pharmaceuticals95 participantsStarted Jun 2016

Fayetteville, Arkansas, United States • Duarte, California, United States • New Haven, Connecticut, United States +12 more locations

The National CT Colonography Trial

Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors

Colorectal Cancer Trials in Other Cities

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum

Improving Care After Chemotherapy

A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581

A Sustainable Approach to Increasing Cancer Screening

Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island

Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)

A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer

Adjuvant Aflibercept for Metastatic Colorectal Cancer

A Study in Second Line Metastatic Colorectal Cancer

A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Other Conditions in Boston